PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.

PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.

Bromo and extra terminal (BET) proteins (BRD2, BRD3, BRD4, and BRDT) are transcriptional regulators required for efficient expression of several growth promoting and antiapoptotic genes as well as for cell-cycle progression. BET proteins are recruited on transcriptionally active chromatin via their...

Bibliografske podrobnosti
Main Authors:	Picaud, S, Da Costa, D, Thanasopoulou, A, Filippakopoulos, P, Fish, P, Philpott, M, Fedorov, O, Brennan, P, Bunnage, M, Owen, DR, Bradner, J, Taniere, P, O'Sullivan, B, Müller, S, Schwaller, J, Stankovic, T, Knapp, S
Format:	Journal article
Jezik:	English
Izdano:	2013

Podobne knjige/članki

Developing chemical probes for the BET bromodomains
od: Hewings, D, et al.
Izdano: (2012)

The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
od: Hay, D, et al.
Izdano: (2013)

Chemical probes for bromodomains outside the BET family
od: Brennan, P, et al.
Izdano: (2013)

Selective inhibition of BET bromodomains.
od: Filippakopoulos, P, et al.
Izdano: (2010)

Selective inhibition of BET bromodomains.
od: Filippakopoulos, P, et al.
Izdano: (2010)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
od: Filippakopoulos, P, et al.
Izdano: (2012)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
od: Filippakopoulos, P, et al.
Izdano: (2012)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.
od: Picaud, S, et al.
Izdano: (2013)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
od: Picaud, S, et al.
Izdano: (2013)

Small-molecule bromodomain inhibitors for cancer therapy
od: Qi, J, et al.
Izdano: (2010)

Promiscuous targeting of bromodomains by Bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia
od: Picaud, S, et al.
Izdano: (2016)

Evaluation of linker length effects on a BET bromodomain probe
od: Traquete, R, et al.
Izdano: (2019)

3,5-Dimethylisoxazoles inhibit the bromodomain-histone protein-protein interaction
od: Hewings, D, et al.
Izdano: (2012)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
od: Philpott, M, et al.
Izdano: (2011)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
od: Philpott, M, et al.
Izdano: (2011)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
od: Hay, D, et al.
Izdano: (2014)

Synthesis and biological investigation of (+)-JD1, an organometallic BET bromodomain inhibitor
od: Hassell-Hart, S, et al.
Izdano: (2019)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.
od: Hewings, D, et al.
Izdano: (2011)

Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction
od: Rooney, T, et al.
Izdano: (2012)

Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.
od: Fedorov, O, et al.
Izdano: (2015)

Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.
od: Fish, P, et al.
Izdano: (2012)

[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
od: Fedorov, O, et al.
Izdano: (2014)

Interactome rewiring following pharmacological targeting of BET bromodomains
od: Lambert, J-P, et al.
Izdano: (2018)

BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability
od: Jennings, L, et al.
Izdano: (2018)

The bromodomain interaction module.
od: Filippakopoulos, P, et al.
Izdano: (2012)

The bromodomain interaction module
od: Filippakopoulos, P, et al.
Izdano: (2012)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands
od: Hewings, D, et al.
Izdano: (2011)

Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding.
od: Kempen, H, et al.
Izdano: (2013)

Bromodomains as therapeutic targets.
od: Muller, S, et al.
Izdano: (2011)

Chemical probes and inhibitors of bromodomains outside the BET family
od: Moustakim, M, et al.
Izdano: (2016)

Targeting bromodomains: epigenetic readers of lysine acetylation.
od: Filippakopoulos, P, et al.
Izdano: (2014)

BET bromodomain inhibitors PFI-1 and CPI-203 suppress the development of follicular lymphoma via regulating Wnt/β-catenin signaling
od: Min Bai, et al.
Izdano: (2024-03-01)

Discovery of BET bromodomain inhibitors and their role in target validation
od: Mueller, S, et al.
Izdano: (2014)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
od: Cribbs, AP, et al.
Izdano: (2021)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
od: Ciceri, P, et al.
Izdano: (2014)

Corrigendum: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
od: Ciceri, P, et al.
Izdano: (2014)

Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.
od: Hewings, D, et al.
Izdano: (2013)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
od: Adam P. Cribbs, et al.
Izdano: (2021-02-01)

BET bromodomain proteins regulate enhancer function during adipogenesis
od: Brown, Jonathan D., et al.
Izdano: (2018)

Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
od: Cheng, Z, et al.
Izdano: (2013)